Literature DB >> 12645700

Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database.

Edward B Savage1, T Bruce Ferguson, Verdi J DiSesa.   

Abstract

BACKGROUND: The Society of Thoracic Surgeons National Cardiac Database data indicate that the performance of mitral repair has increased significantly (1990 to 23.2%, 1999 to 32.0%, p < 0.0001). We examined contemporary (1999 to 2000) usage of mitral repair in the United States.
METHODS: We analyzed National Cardiac Database data to determine the operative approach for a diagnosis of mitral regurgitation.
RESULTS: A total of 21,741 isolated and combined mitral valve procedures were identified. The overall frequency of repair was 37.7% (8206). For procedures isolated to the mitral valve, the frequency of repair was 35.7% (3027/8486) whereas repair was more common with concomitant CABG (42.9% [3088/7193], p < 0.0001). The proportion of patients having repair decreased with age (41.2% [386/936] in 20 to 39 years, 36.1% [3513/9746] in > 70 years, p = 0.0016). Repair was more common in males (43.5% [4720/10860]) than females (32.0% [3472/10842], p < 0.0001). Repair was less common as NYHA Class increased (Class I, 47.8% [949/1984] vs Class IV, 33.2% [1803/5427]) and for emergent operative status (21.2% [156/736] vs 38.5% [8000/20773] for elective/urgent, both p < 0.0001). The number of prior operations did not affect the use of repair. Simple annuloplasty was performed in the majority of reported repairs (62.8% [3837/6115]), more so with associated CABG as compared to isolated repair (70.2% [2167/3088] vs 55.2% [1670/3027]; p < 0.0001).
CONCLUSIONS: Mitral repair was performed in over one-third of the patients reported in 1999 to 2000 and has increased since the National Cardiac Database inception. Repair usage differed based on sex, age, gravity of illness, and associated procedures. This provides a base line from which to expand the application of repair.

Entities:  

Mesh:

Year:  2003        PMID: 12645700     DOI: 10.1016/s0003-4975(02)04645-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

Review 1.  Minimally invasive heart valve surgery: how and why in 2012.

Authors:  Rakesh M Suri; Nassir M Thalji
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Can we predict mitral valve repair rates by individual surgeons' mitral volume?

Authors:  Steven F Bolling
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Current concepts in mitral valve repair for degenerative disease.

Authors:  David H Adams; Anelechi C Anyanwu; Parwis B Rahmanian; Farzan Filsoufi
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

4.  When is your surgeon good enough? When do you need a "referent surgeon"?

Authors:  Patrick M McCarthy
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

Review 5.  Mitral valve repair: we must do a better job.

Authors:  William F Northrup Iii
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

Review 6.  New techniques for percutaneous repair of the mitral valve.

Authors:  Michael J Mack
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

Review 7.  Treatment and management of mitral regurgitation.

Authors:  Michele De Bonis; Francesco Maisano; Giovanni La Canna; Ottavio Alfieri
Journal:  Nat Rev Cardiol       Date:  2011-11-22       Impact factor: 32.419

8.  Interventional vs. surgical mitral valve therapy. Which technique for which patient?

Authors:  M Taramasso; N Buzzatti; G La Canna; A Colombo; O Alfieri; F Maisano
Journal:  Herz       Date:  2013-08       Impact factor: 1.443

Review 9.  Mitral valve repair over five decades.

Authors:  Jerome Jouan
Journal:  Ann Cardiothorac Surg       Date:  2015-07

Review 10.  Current Discoveries and Interventions for Barlow's Disease.

Authors:  Juan A Siordia
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.